文献速递腹部技术与安全US

基于深度学习超声造影与临床因素的联合列线图模型开发与验证:术前预测胰腺神经内分泌肿瘤侵袭性

Development and validation of a combined nomogram model based on deep learning contrast-enhanced ultrasound and clinical factors to predict preoperative aggressiveness in pancreatic neuroendocrine neoplasms.
PubMed 文献 · Eur Radiol · 2022-04-07

本回顾性研究纳入104例组织学证实的胰腺神经内分泌肿瘤患者,基于超声造影图像深度学习预测概率联合肿瘤大小、动脉期增强水平构建列线图模型,用于术前区分侵袭性与非侵袭性肿瘤。联合模型在测试集AUC为0.85(95%CI 0.69-1.00),校准良好,决策曲线分析验证其临床实用性。

要点

  • 联合列线图模型在测试集AUC为0.85(95%CI 0.69-1.00),校准良好。
  • 肿瘤大小(OR 1.58,p=0.02)、动脉期增强水平(OR 0.04,p=0.008)和深度学习预测概率(OR 288.46,p<0.001)为独立预测因子。
  • 联合模型预测侵袭性优于临床模型(AUC 0.97 vs 0.87,p=0.009)。

核心结论

  • 基于深度学习超声造影和临床因素的联合列线图模型可作为术前无创、精准评估工具,用于区分侵袭性与非侵袭性胰腺神经内分泌肿瘤。

研究设计与样本

  • 回顾性研究,纳入2010年1月至2020年10月初诊时接受超声造影检查且组织学证实为胰腺神经内分泌肿瘤的连续患者104例,随机分为训练集80例(平均年龄47岁±12,男56例)和测试集24例(平均年龄50岁±12,男14例);采用典型超声及增强图像微调SE-ResNeXt-50网络,通过多因素logistic回归构建联合列线图模型,并以受试者工作特征曲线、校准曲线和决策曲线分析评估模型。

诊断标准与关键数值

  • 深度学习模型在测试集AUC为0.81(95%CI 0.62-1.00);联合列线图模型(纳入肿瘤大小、动脉期增强水平、深度学习预测概率)在测试集AUC为0.85(95%CI 0.69-1.00),校准良好;联合模型在训练集AUC为0.97,测试集AUC为0.85。

临床应用与阅片要点

  • 作者认为联合列线图模型可作为术前无创、精准评估工具,用于区分侵袭性与非侵袭性胰腺神经内分泌肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to develop and validate a combined nomogram model based on deep learning (DL) contrast-enhanced ultrasound (CEUS) and clinical factors to preoperatively predict the aggressiveness of pancreatic neuroendocrine neoplasms (PNENs).

METHODS: In this retrospective study, consecutive patients with histologically proven PNENs underwent CEUS examination at the initial work-up between January 2010 and October 2020. Patients were randomly allocated to the training and test sets. Typical sonographic and enhanced images of PNENs were selected to fine-tune the SE-ResNeXt-50 network. A combined nomogram model was developed by incorporating the DL predictive probability with clinical factors using multivariate logistic regression analysis. The utility of the proposed model was evaluated using receiver operator characteristic, calibration, and decision curve analysis.

RESULTS: A total of 104 patients were evaluated, including 80 (mean age ± standard deviation, 47 years ± 12; 56 males) in the training set and 24 (50 years ± 12; 14 males) in the test set. The DL model displayed effective image recognition with an AUC of 0.81 (95%CI: 0.62-1.00) in the test set. The combined nomogram model that incorporated independent clinical risk factors, such as tumor size, arterial enhancement level, and DL predictive probability, showed strong discrimination, with an AUC of 0.85 (95%CI: 0.69-1.00) in the test set with good calibration. Decision curve analysis verified the clinical usefulness of the combined nomogram.

CONCLUSIONS: The combined nomogram model could serve as a preoperative, noninvasive, and precise evaluation tool to differentiate aggressive and non-aggressive PNENs.

KEY POINTS: • Tumor size (odds ratio [OR], 1.58; p = 0.02), arterial enhancement level (OR, 0.04; p = 0.008), and deep learning predictive probability (OR, 288.46; p < 0.001) independently predicted aggressiveness of pancreatic neuroendocrine neoplasms preoperatively. • The combined model predicted aggressiveness better than the clinical model (AUC: 0.97 vs. 0.87, p = 0.009), achieving AUC values of 0.97 and 0.85 in the training set and the test set, respectively.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Huang, Xie, Wu, et al. Development and validation of a combined nomogram model based on deep learning contrast-enhanced ultrasound and clinical factors to predict preoperative aggressiveness in pancreatic neuroendocrine neoplasms. Eur Radiol. 2022. PMID: 35389050. doi:10.1007/s00330-022-08703-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。